Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1993-03-16
1997-06-03
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
252312, 252314, 514757, 514761, 514832, 514833, A61K 3102, B01J 1300
Patent
active
056355386
ABSTRACT:
A fluorocarbon emulsion which exhibits reduced pulmonary gas-trapping properties in species-sensitive laboratory animals is disclosed. Additionally, the fluorocarbon component(s) exhibit short organ retention time(s). The emulsion includes an aqueous phase, an emulsifier, and a fluorocarbon (or fluorocarbon composition), having a vapor pressure of less than about 8 torr to reduce pulmonary gas-trapping, and having an organ retention half life of less than about 6 weeks and more preferably less than about 3 to 4 weeks.
REFERENCES:
patent: 3975512 (1976-08-01), Long
patent: 4613708 (1986-09-01), Riess et al.
patent: 4640833 (1987-02-01), Tamborski et al.
patent: 4859363 (1989-08-01), Davis et al.
patent: 4865836 (1989-09-01), Long, Jr.
patent: 4866096 (1989-09-01), Schweighardt
patent: 4895876 (1990-01-01), Schweighardt et al.
patent: 4987154 (1991-01-01), Long, Jr.
patent: 5120731 (1992-06-01), Meinert et al.
patent: 5264220 (1993-11-01), Long, Jr. et al.
patent: 5393513 (1995-02-01), Long, Jr.
Lawson et al., "Methods for the Estimation of Vapor Pressures and Oxygen Solubilities of Fluorochemicals for Possible Application in Artificial Blood Formulations", Journal of Fuorine Chemistry, 12(1978) pp. 221-236.
Clark, et al. "Response of the Rabbit Lung as a Criterion of Safety for Fluorocarbon Breathing and Blood Substitutes" Biomat. Art. Cells & Immob. Biotech. 20(2-4): 1085-1099 (1992). (month unknown).
Geyer, R. "Whole Animal Perfusion with Fluorocarbon Dispersions" Federation Procedures 29(5): 1758-1763 (1970).
Kabal'nov, et al. "Influence of Nature and Composition od Disperse Phase in Emulsions of Perfluoroorganic Compounds on the Kinetics of the Decrease in Emulsion Dispersity" Kolloidnyi Zhurnal 48(1): 20-24 (1986).
Riess, J. "Reassessment of Criteria for the Selection of Perfluorochemicals for Second-Generation Blood Substitutes: Analysis of Structure/Property Relationships" Artificial Organs 8(1): 44-56 (1984).
Riess, et al. "Post-Fluosol Progress in Fluorocarbon Emulsions for in vivo Oxygen Delivery" International Symposium on Artificial Blood Substitutes, Bari. Italy, 135-166 (1987).
Keipert Peter E.
Pelura Timothy J.
Schutt Ernest G.
Weers Jeffry G.
Alliance Pharmaceutical Corp.
Lovering Richard D.
Metzmaier Daniel S.
LandOfFree
Fluorocarbon emulsions with reduced pulmonary gas-trapping prope does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorocarbon emulsions with reduced pulmonary gas-trapping prope, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorocarbon emulsions with reduced pulmonary gas-trapping prope will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-392154